Gator Capital Management LLC Purchases New Stake in Kenvue Inc. $KVUE

Posted by Francis Steltz on Jun 13th, 2026

Gator Capital Management LLC purchased a new stake in Kenvue Inc. (NYSE:KVUE – Free Report) during the fourth quarter, HoldingsChannel reports. The firm purchased 78,564 shares of the company’s stock, valued at approximately $1,355,000.

A number of other large investors have also added to or reduced their stakes in the business. Physician Wealth Advisors Inc. increased its position in Kenvue by 67.5% during the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after buying an additional 618 shares during the period. Elyxium Wealth LLC bought a new position in Kenvue during the 4th quarter worth $26,000. SBI Securities Co. Ltd. increased its position in Kenvue by 82.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock worth $39,000 after buying an additional 1,027 shares during the period. Leonteq Securities AG bought a new position in Kenvue during the 4th quarter worth $45,000. Finally, Hantz Financial Services Inc. increased its position in Kenvue by 157.2% during the 3rd quarter. Hantz Financial Services Inc. now owns 2,850 shares of the company’s stock worth $46,000 after buying an additional 1,742 shares during the period. Institutional investors own 97.64% of the company’s stock.

Insider Transactions at Kenvue

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.59% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Weiss Ratings cut Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 29th. UBS Group lowered their price objective on Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 7th. Canaccord Genuity Group increased their price objective on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Wednesday, February 18th. Barclays lowered their price objective on Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 14th. Finally, Zacks Research upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have issued a Hold rating to the stock. According to MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and a consensus target price of $19.33.

Get Our Latest Stock Analysis on KVUE

Kenvue Stock Up 0.3%

Shares of NYSE KVUE opened at $18.13 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $22.87. The stock has a market capitalization of $34.80 billion, a P/E ratio of 21.32, a PEG ratio of 1.37 and a beta of 0.54. The stock’s fifty day moving average is $17.43 and its 200 day moving average is $17.53.

Kenvue (NYSE:KVUE – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $3.84 billion. During the same quarter in the previous year, the business posted $0.24 earnings per share. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. Sell-side analysts forecast that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date was Wednesday, May 13th. Kenvue’s payout ratio is currently 97.65%.

Kenvue Company Profile

(Free Report)

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.